Shaw, Executive Chairperson of Biocon & Biocon Biologics, said the pharma industry faces long 'lab-to-market' timelines, high ...

The company is also focused on strategic capital deployment. It has already invested in GLP-1 drug substance and drug product ...

India trade relations prompted foreign investors to flee companies exposed to tariff risks, but retail investors ...

Trading at Rs 367.85, Biocon shows a positive move in today's early trading session, with the stock included in the Nifty Midcap 150 index.

Despite Modi’s rhetoric of “Viksit Bharat”, record numbers of Indians renounce citizenship for jobs, dignity, and stability ...

ICICI Securities is bearish on Biocon has recommended sell rating on the stock with a target price of Rs 270 in its research report dated August 09, 2025.

Vana Charitable Trust partners with Syngene Biocon Foundation to restore mangroves along Netravathi riverbank in Mangaluru.

Prime Minister Narendra Modi on Friday asked scientists and entrepreneurs to focus more on research and development (R&D), ...

Biocon Limited ( ($IN:BIOCON) ) has provided an update. Biocon Limited has released the transcript of its Q1 FY26 earnings call, which was held on ...

Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research ...

National Integration Tour concludes in Sikkim, fostering national unity among youth. Sikkim Governor lauds Indian Army's ...

The Ulcerative Colitis treatment paradigm is undergoing a dynamic evolution, marked by increasing therapeutic interventions ...